Purchase Order HHSN261201600366P

<p>This is a $1,784.00 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency, to Battelle Memorial Institute for initial administrative charges related to a pre-clinical toxicology study of a drug being developed for cancer patients. The contract is an order placed under the Toxicology of Drugs Developed for Cancer Patients indefinite-delivery indefinite-quantity (IDIQ) contract vehicle. No set-aside was used for this award.</p>

<p>This is a firm-fixed-price purchase order for laboratory analysis services awarded by the National Cancer Institute, a civilian federal agency, to an unspecified prime contractor. The contract has a ceiling value of $11,075.00 and a period of performance ending on June 30, 2024. No set-aside designation is indicated. The place of performance is Rockville, Maryland.</p>

This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $157,158 contract is for the characterization of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drug candidates using standardized in vitro methods. This work supports...

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a &quot;Kick Off Meeting, Preclinical Pharmacokinetic &amp; Pharmacology Evaluations of Agents Being Developed for Cancer Patients&quot; with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...

This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences, a civilian federal agency, to Transomic Technologies, Inc. for $49,950.00. The contract has an ultimate completion date of December 31, 2015 and was not set aside. The contract does not appear to be associated with a larger contracting vehicle, and the provided information does not indicate any major subcontractors. Based on the agency, the contract is likely related to the National...

This is a Cost Plus Fixed Fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The contract is for an exploratory toxicology study in dogs of an MCL-1 inhibitor drug being developed for cancer and other diseases. The contract has a potential value of $116,039 and a completion date of June 30, 2021. It is a task...

This is a delivery order worth $3,102 awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute, a nonprofit research and development organization, for a contract orientation meeting related to preclinical pharmacology and toxicology studies. The delivery order was issued under a larger Preclinical Pharmacology and Toxicology Studies contract vehicle that runs from 2012 to 2014. The award does not have a set-aside designation. Battelle frequently partners with universities...

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $134,550 firm-fixed-price purchase order to Biosimulation Consulting Inc., a for-profit organization, to build physiologically-based pharmacokinetic (PBPK) models. The purpose is to predict the fate of contaminants in populations identified in the Anniston Community Health Survey, also known as the Anniston Project. The award is not set aside for any specific business...